Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong · Delayed Price · Currency is HKD 1.050
0.00 (0.00%)
Jun 1, 2026, 2:47 PM HKT
HKG:2348 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,579 | 1,834 | 1,832 | 1,575 | 1,993 | 2,502 | |
Market Cap Growth | -9.39% | 0.10% | 16.32% | -20.98% | -20.34% | 18.77% |
Enterprise Value | -343 | 68 | 221 | 503 | 1,004 | 1,638 |
Last Close Price | 1.05 | 1.17 | 1.08 | 0.86 | 1.02 | 1.19 |
PE Ratio | 6.74 | 7.70 | 3.05 | 4.39 | 4.93 | 5.69 |
Forward PE | - | 8.59 | 8.59 | 8.59 | 8.59 | 8.59 |
PS Ratio | 1.15 | 1.34 | 1.62 | 1.24 | 1.38 | 1.75 |
PB Ratio | 0.42 | 0.49 | 0.52 | 0.50 | 0.67 | 0.85 |
P/TBV Ratio | 0.47 | 0.55 | 0.59 | 0.58 | 0.77 | 1.00 |
P/FCF Ratio | 5.27 | 6.12 | 18.29 | 10.30 | 7.67 | 25.46 |
P/OCF Ratio | 3.99 | 4.64 | 7.82 | 4.22 | 4.06 | 5.19 |
EV/Sales Ratio | - | 0.05 | 0.20 | 0.40 | 0.70 | 1.15 |
EV/EBITDA Ratio | - | 0.18 | 0.69 | 1.29 | 1.85 | 3.08 |
EV/EBIT Ratio | - | 0.27 | 1.03 | 1.65 | 2.12 | 3.51 |
EV/FCF Ratio | -1.15 | 0.23 | 2.21 | 3.29 | 3.87 | 16.67 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.04 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 0.22 | 0.22 | 0.11 | 0.34 | 0.02 | 0.05 |
Debt / FCF Ratio | 0.29 | 0.29 | 0.37 | 0.87 | 0.04 | 0.29 |
Net Debt / Equity Ratio | -0.51 | -0.51 | -0.47 | -0.37 | -0.40 | -0.34 |
Net Debt / EBITDA Ratio | -5.03 | -5.03 | -5.19 | -2.97 | -2.24 | -1.86 |
Net Debt / FCF Ratio | -6.41 | -6.41 | -16.71 | -7.58 | -4.67 | -10.07 |
Asset Turnover | 0.31 | 0.31 | 0.28 | 0.32 | 0.36 | 0.37 |
Inventory Turnover | 2.57 | 2.57 | 2.03 | 2.31 | 2.30 | 2.18 |
Quick Ratio | 4.19 | 4.19 | 3.38 | 2.24 | 1.59 | 1.72 |
Current Ratio | 4.64 | 4.64 | 3.97 | 2.57 | 1.87 | 2.17 |
Return on Equity (ROE) | 6.29% | 6.29% | 18.20% | 11.71% | 14.10% | 15.46% |
Return on Assets (ROA) | 3.55% | 3.55% | 3.31% | 4.73% | 7.47% | 7.62% |
Return on Invested Capital (ROIC) | 11.60% | 11.28% | 10.03% | 12.72% | 21.48% | 21.80% |
Return on Capital Employed (ROCE) | 6.50% | 6.50% | 5.80% | 9.30% | 15.30% | 14.40% |
Earnings Yield | 15.08% | 12.98% | 32.81% | 22.80% | 20.31% | 17.57% |
FCF Yield | 18.99% | 16.35% | 5.47% | 9.71% | 13.04% | 3.93% |
Dividend Yield | 6.00% | 5.40% | 5.86% | 9.25% | 8.62% | 6.71% |
Payout Ratio | 62.12% | 62.12% | 19.68% | 35.91% | 27.80% | 40.18% |
Buyback Yield / Dilution | 0.14% | 0.14% | -0.22% | -0.02% | 0.37% | 2.44% |
Total Shareholder Return | 6.14% | 5.54% | 5.64% | 9.23% | 8.99% | 9.14% |